|

ALTO-300 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Alto Neuroscience1

Indications

  • Major Depressive Disorder1
  • Depression1

Phoenix, Arizona1 trial

Study of ALTO-300 in MDD

Site 200

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.